Invicta Diagnostic Ltd
Incorporated in January 2021, Invicta Diagnostic Limited offers radiology and pathology solutions [1]
- Market Cap ₹ 107 Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E 22.8
- Book Value ₹
- Dividend Yield %
- ROCE 46.4 %
- ROE 32.3 %
- Face Value ₹ 10.0
Pros
- Debtor days have improved from 27.6 to 17.7 days.
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 7.46 | 7.99 | 30.10 | |
| 4.22 | 4.59 | 21.09 | |
| Operating Profit | 3.24 | 3.40 | 9.01 |
| OPM % | 43.43% | 42.55% | 29.93% |
| 0.00 | 0.35 | 0.57 | |
| Interest | 0.02 | 0.08 | 0.23 |
| Depreciation | 0.95 | 0.98 | 2.49 |
| Profit before tax | 2.27 | 2.69 | 6.86 |
| Tax % | 22.91% | 0.00% | 31.63% |
| 1.76 | 2.69 | 4.69 | |
| EPS in Rs | |||
| Dividend Payout % | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 277% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 74% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 32% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Equity Capital | 0.13 | 8.42 | |
| Reserves | 12.05 | 8.41 | |
| 1.87 | 1.67 | ||
| 1.79 | 2.75 | ||
| Total Liabilities | 15.84 | 21.25 | |
| 11.78 | 9.62 | ||
| CWIP | 0.00 | 0.00 | |
| Investments | 0.00 | 4.33 | |
| 4.06 | 7.30 | ||
| Total Assets | 15.84 | 21.25 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 4.21 | 6.47 | ||
| -10.01 | -5.23 | ||
| 7.14 | -0.42 | ||
| Net Cash Flow | 1.34 | 0.83 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Debtor Days | 37.46 | 17.70 | |
| Inventory Days | 296.56 | 83.33 | |
| Days Payable | 1,102.60 | 70.00 | |
| Cash Conversion Cycle | -768.58 | 31.04 | |
| Working Capital Days | 5.94 | 21.58 | |
| ROCE % | 46.45% |
Documents
Annual reports
No data available.
Business Profile[1]
PC Diagnostics (Invicta) is a diagnostic chain in the Mumbai Metropolitan Region (MMR) offering radiology and pathology services. The company operates 7 diagnostic centres + 1 centralised laboratory, built on a hub-and-spoke model.